355 related articles for article (PubMed ID: 23394580)
21. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Cochrane DR; Spoelstra NS; Howe EN; Nordeen SK; Richer JK
Mol Cancer Ther; 2009 May; 8(5):1055-66. PubMed ID: 19435871
[TBL] [Abstract][Full Text] [Related]
23. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
24. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
25. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
27. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
Tang W; Ren A; Xiao H; Sun H; Li B
Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
[TBL] [Abstract][Full Text] [Related]
28. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells.
Lobert S; Graichen ME; Morris K
Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of patupilone resistance.
Mozzetti S; Iantomasi R; De Maria I; Prislei S; Mariani M; Camperchioli A; Bartollino S; Gallo D; Scambia G; Ferlini C
Cancer Res; 2008 Dec; 68(24):10197-204. PubMed ID: 19074887
[TBL] [Abstract][Full Text] [Related]
31. HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability.
Yu X; Li Y; Ding Y; Zhang H; Ding N; Lu M
Cell Biochem Biophys; 2020 Dec; 78(4):447-453. PubMed ID: 32901414
[TBL] [Abstract][Full Text] [Related]
32. A Regulatory Loop Involving miR-200c and NF-κB Modulates Mortalin Expression and Increases Cisplatin Sensitivity in an Ovarian Cancer Cell Line Model.
Huang X; Yan Y; Gui A; Zhu S; Qiu S; Chen F; Liu W; Zuo J; Yang L
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499626
[TBL] [Abstract][Full Text] [Related]
33. A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer.
Yang J; Wu SP; Wang WJ; Jin ZR; Miao XB; Wu Y; Gou DM; Liu QZ; Yao KT
Exp Cell Res; 2020 Jun; 391(2):111817. PubMed ID: 32179097
[TBL] [Abstract][Full Text] [Related]
34. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
35. Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
Prislei S; Martinelli E; Zannoni GF; Petrillo M; Filippetti F; Mariani M; Mozzetti S; Raspaglio G; Scambia G; Ferlini C
Oncotarget; 2015 Aug; 6(22):18966-79. PubMed ID: 26136338
[TBL] [Abstract][Full Text] [Related]
36. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels.
Abdelmohsen K; Srikantan S; Kuwano Y; Gorospe M
Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20297-302. PubMed ID: 19088191
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin Gamma Catalytic Subunit PPP3CC Inhibition by miR-200c-3p Affects Apoptosis in Epithelial Ovarian Cancer.
Anastasiadou E; Messina E; Sanavia T; Labruna V; Ceccarelli S; Megiorni F; Gerini G; Pontecorvi P; Camero S; Perniola G; Venneri MA; Trivedi P; Lenzi A; Marchese C
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573382
[TBL] [Abstract][Full Text] [Related]
38. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
Gao YC; Wu J
Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
